LSD Studies With Autistic Children

See also:    Autism: History & Myths    Psychiatry   

Internet Resources

Archives of General Psychiatry, 1962; 6 (203-213)
A.M. Freedman et al
Archive of information on the use of psychoactive drugs.
Psychotomimetic Drugs, 1970; pp. 265-273
Lauretta Bender
Science, 1968; 159:749
Lauretta Bender et al
In the children's unit of Creedmore State Hospital with a resident population of 450 patients, ages 4 to 15, we have investigated the responses of some of these children to lysergic acid and related drugs in the psychiatric, psychological and biochemical areas. Two groups of boys receiving daily LSD, UML (which is a methylated derivative of LSD) or psilocybin ... at first the medication was given weekly but was eventually given daily for periods of up to several months. Dosages remain constant throughout, LSD 150 mcg. (which is a standard for an adult trip), psilocybin 20 mg. daily or UML 12 mg. daily, all given in two divided doses. The average duration of treatment was 2 to 3 months. Daily. Children, 7, 9 , 11 years old ...
John Rappoport
Diseases of the Nervous System, 27:43-46 1966
Lauretta Bender
(LSD) aroused the interest of many psychiatrists who were in no sense cultural rebels or especially radical in their attitudes. It was recommended for a wide variety of problems including alcoholism, obsessional neurosis, and childhood autism.
Christopher D. Lovett
Recent Advances in Biological Psychiatry, 5:84-92, 1963
Lauretta Bender et al
American Druggist, 146 (13):33, 1962
Lauretta Bender et al
American Journal of Psychiatry, May 1966, pp. 1201-1211
James Q. Simmons III, O. Ivar Lovaas, et al
Archives of General Psychiatry 25: 498-510
Julian Silverman
Acta paedopsychiatrica, 34:298-307, 1968
Lauretta Bender
Recent Advances in Biological Psychiatry, 1962; 4:170-77
Lauretta Bender et al
Now that the FDA has permitted research with LSD and psilocybin to resume, we feel it is important to share examples of a remarkable experiment, the results of which were not sufficiently taken into account because this line of research was prematurely halted in the mid-sixties due to political considerations. Childhood schizophrenia is still a difficult problem to treat and causes much suffering. It is a terrible shame that research done 35 years ago is still the last word on the use of psychedelics to treat these conditions.
Gary Fischer, Newsletter of the Multidisciplinary Association for Psychedelic Studies
Biological Treatment of Mental Illness, Proceedings II of the International Conference of the Manfred Sakel Foundation 10/31-11/3/1962, 1966; 2(4):463-91
Lauretta Bender et al
Journal of Asthma Research, 5: 139-143 (1967)
Harold A. Abramson
Behavioral Neuropsychiatry 1969 Nov;1(8):44-50
Robert E. Mogar, Robert W. Aldrich

Opinions expressed by the authors of pages to which this site links do not necessarily reflect this site developer's opinions. In other words: Sublime or ridiculous? You decide!
Copyright © 2004-2008, Kathleen Seidel. All rights reserved.
This page was last updated on 5 November 2008, 3:48 pm
Hosted by TextDrive